病例报告:Ofatumumab治疗抗DPPX自身免疫脑炎的治疗方法
Peicai Fu1, Zhenqiong Hu2, Guopeng Zhang3
1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Frontiers in immunology
|July 15, 2024
概括
本研究详细介绍了使用ofatumumab的第一个成功治疗Dipeptidyl peptidase-like protein 6 (DPPX) 抗体脑炎的成功治疗方法. 这种罕见的自身免疫性疾病对标准疗法耐药,在这种新的方法下显著改善.
科学领域:
- 神经免疫学 神经免疫学
- 自免疫神经学 自免疫神经学
背景情况:
- 双基酸酶样蛋白6 (DPPX) 抗体脑炎是一种罕见的自身免疫神经系统疾病.
- 对DPPX脑炎的诊断和管理具有挑战性,特别是在耐火病例中.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509